Call us Become a distributor
Tablet Antibiotics & Anti-infectives

Cefaxil-CV

“Adding diamond to gold, added power to eradicate”

A cefixime and clavulanate combination tablet for respiratory, ENT and urinary tract infections.

Cefaxil-CV product information card showing composition and indications Tap to enlarge

Original Cefaxil-CV product literature

Composition
Cefixime 200 mg + Potassium Clavulanate 125 mg
Dosage form
Tablet

Indications

  • Respiratory tract infections: bronchitis, bronchiectasis, pneumonia
  • ENT infections: chronic maxillary sinusitis, chronic otitis media
  • Urinary tract infections, uncomplicated and complicated

Key points

  • Orally active third generation bactericidal drug
  • Demonstrated broad spectrum activity
  • Highly stable in the presence of beta-lactamase
  • One tablet twice daily for 7 to 14 days
Prescription note. This page reproduces the manufacturer's product literature for reference by healthcare professionals and trade partners. It is not a substitute for medical advice. Use only as directed by a registered medical practitioner.

Related

More in Antibiotics & Anti-infectives